Product
GTX-101
1 clinical trial
1 indication
Indication
Postherpetic NeuralgiaClinical trial
Parallel Study to Evaluate the Pharmacokinetics, Dose Proportionality, Safety and Tolerability of GTX-101 (Bupivacaine Hydrochloride Metered Dose Spray) and Subcutaneous Injectable Bupivacaine in Healthy SubjectsStatus: Active (not recruiting), Estimated PCD: 2022-08-21